Advertisement
Canada markets close in 4 hours 20 minutes
  • S&P/TSX

    21,869.02
    -142.70 (-0.65%)
     
  • S&P 500

    5,065.36
    -5.19 (-0.10%)
     
  • DOW

    38,374.63
    -129.06 (-0.34%)
     
  • CAD/USD

    0.7288
    -0.0032 (-0.44%)
     
  • CRUDE OIL

    82.91
    -0.45 (-0.54%)
     
  • Bitcoin CAD

    89,076.86
    -2,317.77 (-2.54%)
     
  • CMC Crypto 200

    1,403.52
    -20.58 (-1.45%)
     
  • GOLD FUTURES

    2,342.70
    +0.60 (+0.03%)
     
  • RUSSELL 2000

    1,989.45
    -13.20 (-0.66%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ

    15,728.62
    +31.98 (+0.20%)
     
  • VOLATILITY

    16.14
    +0.45 (+2.86%)
     
  • FTSE

    8,038.39
    -6.42 (-0.08%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6815
    -0.0021 (-0.31%)
     

Gilead Sciences: An Update for Investors

Gilead Sciences: An Update for Investors

For Gilead Sciences’ (GILD) Biktarvy, declining revenues and stock price movements have kept investors interested in the stock. In this series, we’ll explore Gilead Sciences’ financials, the performance of the company’s geographic segments, analysts’ recommendations for the stock, and the company’s valuation metrics.